Clinical

Dataset Information

0

A Two Part Study in Japanese Patients With mCRC, Consisting of an Open-Label Phase I Part to Assess the Safety and Tolerability of AZD2171 in Combination With FOLFOX Followed by a Phase II, Randomised, Double-Blind, Parallel Group Study to Assess the Efficacy of AZD2171 in Combination With FOLFOX


ABSTRACT: Interventions: investigational material(s) Generic name etc : AZD2171 INN of investigational material : Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : Oral Primary outcome(s): Efficacy Primary Outcome Measures:- Progression of Metastatic Colorectal Cancer (mCRC) - PFS Secondary Outcome Measures: - Safety and tolerability [Time Frame: assessed at each visit] Study Design: Randomized, Double-Blind, Placebo Control, Parallel Assignment Study

DISEASE(S): Metastatic Colorectal Cancer

PROVIDER: 99530 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2610037 | ecrin-mdr-crc
| 2041551 | ecrin-mdr-crc
| 2030216 | ecrin-mdr-crc
| 97778 | ecrin-mdr-crc
| S-EPMC3253323 | biostudies-literature
| 99274 | ecrin-mdr-crc
| 100185 | ecrin-mdr-crc
| S-EPMC10235118 | biostudies-literature
| 97953 | ecrin-mdr-crc
| 98039 | ecrin-mdr-crc